SERM Medical Director, Oncology
Business Introduction At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D; focuses on discovering and delivering vaccines and medicines, combining our understanding of the immune system with cutting-edge technology to transform people’s lives. GSK fosters a culture ambitious for patients, accountable for impact, and committed to doing the right thing, making sure that we focus our efforts on accelerating significant assets that meet patients’ needs and have the highest probability of success. We’re uniting science, technology, and talent to get ahead of disease together. Find out more: [Our approach to R&D;](#)
Position Summary Provides medical and scientific leadership in the safety evaluation and risk management of GSK’s oncology assets in clinical development. Responsible for the interpretation of safety data, identification and escalation of safety signals, and delivery of clear, evidence-based recommendations to support vantaggi–risk decisions. This role contributes to global governance and plays a critical part in protecting patient safety and shaping the safety profile of innovative oncology medicines. Key Responsibilities Scientific / Medical & Pharmacovigilance Expertise
- Lead pharmacovigilance and risk management activities for assigned oncology assets and clinical trials
- Defi
Position Summary Provides medical and scientific leadership in the safety evaluation and risk management of GSK’s oncology assets in clinical development. Responsible for the interpretation of safety data, identification and escalation of safety signals, and delivery of clear, evidence-based recommendations to support vantaggi–risk decisions. This role contributes to global governance and plays a critical part in protecting patient safety and shaping the safety profile of innovative oncology medicines. Key Responsibilities Scientific / Medical & Pharmacovigilance Expertise
- Lead pharmacovigilance and risk management activities for assigned oncology assets and clinical trials
- Defi